HPV vaccines effective in reducing cervical cancer deaths: A decade of progress
Swati Deshmukh December 2, 2024: The human papillomavirus (HPV) vaccine is significantly reducing cervical cancer deaths in the United States, finds a study.
Swati Deshmukh December 2, 2024: The human papillomavirus (HPV) vaccine is significantly reducing cervical cancer deaths in the United States, finds a study.
Bharti Jayshankar November 30, 2024: A study done by the University of Texas MD Anderson Cancer Center revealed that some breast cells in healthy
Bharti Jayshankar November 29, 2024: Certain hormone replacement therapy (HRT) pills significantly elevate the risk of heart disease and serious blood clots in
Bharti Jayshankar November 29, 2024: Around half a billion people live with asthma and chronic obstructive pulmonary disease (COPD). The Global Burden of
Switzerland’s F. Hoffmann-La Roche AG will buy US-based biopharmaceutical company Poseida Therapeutics for $1.5 billion, according to a statement from the Basel-headquartered company.
Cassava Sciences Inc., a US-based biotechnology firm, announced its controversial experimental oral molecule to treat Alzheimer’s Disease has failed in last-stage trials.
Global representatives at a climate conference signed a $300 billion-a-year deal to finance emissions reductions — a move developing nations say falls way
HQ Team November 23, 2024: Dengue fever cases have almost doubled each year since 2021. This year saw more than 12.7 million cases in total